Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-24

FDA Approved: RANOLAZINE — Supplemental Application (Radha Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved a supplemental application for Ranolazine from Radha Pharmaceuticals, Inc. This is a modification to the previously approved product, though th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

SUPPL AP for RANOLAZINE (RANOLAZINE)